Bayer Managers Hit the Road to Spell Out Monsanto Bid Rationale

  • Baumann’s team is heading to London, Frankfurt and U.S.
  • German company has seen $14 billion eroded from market value

Why Investors Aren't Convinced on Bayer, Monsanto Deal

On Monday, Bayer AG executives took to the phones and the press to tell investors why a $62 billion bid for Monsanto Co. makes sense. Now they’re using a more personalized approach.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.